Cite
DeWire MD, Fuller C, Campagne O, et al. A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study. Clin Cancer Res. 2021;27(9):2442-2451doi: 10.1158/1078-0432.CCR-20-4078.
DeWire, M. D., Fuller, C., Campagne, O., Lin, T., Pan, H., Young Poussaint, T., Baxter, P. A., Hwang, E. I., Bukowinski, A., Dorris, K., Hoffman, L., Waanders, A. J., Karajannis, M. A., Stewart, C. F., Onar-Thomas, A., Fouladi, M., & Dunkel, I. J. (2021). A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(9), 2442-2451. https://doi.org/10.1158/1078-0432.CCR-20-4078
DeWire, Mariko D, et al. "A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,9 (2021): 2442-2451. doi: https://doi.org/10.1158/1078-0432.CCR-20-4078
DeWire MD, Fuller C, Campagne O, Lin T, Pan H, Young Poussaint T, Baxter PA, Hwang EI, Bukowinski A, Dorris K, Hoffman L, Waanders AJ, Karajannis MA, Stewart CF, Onar-Thomas A, Fouladi M, Dunkel IJ. A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study. Clin Cancer Res. 2021 May 01;27(9):2442-2451. doi: 10.1158/1078-0432.CCR-20-4078. Epub 2021 Feb 05. PMID: 33547201; PMCID: PMC8132306.
Copy
Download .nbib
